- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT06442930
Complicanze correlate all'EXTUBE: lo studio EXTUBE (EXTUBE) (EXTUBE)
Complicazioni correlate all'EXtubazione: uno studio osservazionale internazionale per comprenderne l'impatto e le migliori pratiche in sala operatoria e nell'unità di terapia intensiva: lo studio EXTUBE
EXTUBE is an international, multicentre, prospective cohort study evaluating the incidence, risk factors, and outcomes of extubation-related complications and describing clinical practices related to extubation after general anesthesia or after critical illness in the operating room (OR), out of OR anesthesia location or intensive care unit (ICU).
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
Globally, over 200 million people each year require extubation. While routinely performed, extubation is a skilled and potentially high-risk procedure that should be performed only when physiologic, pharmacologic, and contextual conditions are optimal. Complications at this stage of patient care can result in decreased oxygen delivery to the brain and body, sometimes leading to serious adverse events such as cardiac arrest, brain damage, or death. Indeed, one quarter of airway complications that result in death or brain death occur at the time of extubation.
Despite the frequency of extubation and the potential for life-threatening complications, there is a lack of systematic data on the rate and circumstances under which these severe complications occur. The limited data indicate 10-30% of extubations may lead to severe complications, depending on the population and outcome definition. However, the certainty of these estimates is severely limited because they are based on studies that are small, mostly single-center, based on clinician recall, only capture a small portion of extubation complications (e.g., malpractice claims), or do not reflect current clinical practice. In addition, most lack a denominator and exclude successful extubations, making estimates of actual complication rates and risk factors impossible.
There has been no large study of extubation techniques or adherence to guidelines, so procedural factors associated with complications must be elucidated. While adherence to clinical practice guidelines has not been formally evaluated, surveys show non-adherence to some best practices and considerable variation in practice, and data from audits and medicolegal claims show that lack of adherence to best practices is frequently at the root cause of severe adverse extubation outcomes, with half of the complications deemed preventable. Therefore, data on the frequency and nature of extubation complications, patient and procedural risk factors for complications, and guideline adherence rates are needed before these preventable events can be addressed.
EXTUBE (EXtubation related complications - an international observational study To Understand the impact and BEst practices in the operating room and intensive care unit) is an international, multicenter, prospective cohort study
The primary objective of this study is to estimate the incidence of immediate complications related to extubation in adult patients after general anesthesia and/or after critical illness. The secondary objectives are to determine: 1) the incidence of mild extubation complications; 2) patient- and procedure-related risk factors for extubation complications; 3) the association between extubation complications and outcomes until hospital discharge; and 4) the rate of adherence to extubation clinical practice guidelines.
Tipo di studio
Iscrizione (Stimato)
Contatti e Sedi
Contatto studio
- Nome: Matteo Parotto, MD, PhD
- Numero di telefono: +1 416 340 3567
- Email: matteo.parotto@uhn.ca
Backup dei contatti dello studio
- Nome: Shayan Wasim, MPH, BSc
- Numero di telefono: 4221 +1 416 340 4800
- Email: shayan.wasim@uhn.ca
Luoghi di studio
-
-
New South Wales
-
Sydney, New South Wales, Australia, 2065
- Completato
- Royal North Shore Hospital
-
-
Victoria
-
Melbourne, Victoria, Australia, 3135
- Completato
- Eastern Health - Maroondah Hospital
-
Melbourne, Victoria, Australia, 3156
- Completato
- Eastern Health - Angliss Hospital
-
Melbourne, Victoria, Australia, 3076
- Completato
- The Northern Hospital
-
Melbourne, Victoria, Australia, 3128
- Completato
- Eastern Health - Box Hill Hospital
-
Melbourne, Victoria, Australia, 3084
- Completato
- Austin Health - Austin Hospital
-
Melbourne, Victoria, Australia, 3079
- Completato
- Austin Health - Heidelberg Repatriation Hospital
-
-
-
-
British Columbia
-
Surrey, British Columbia, Canada, V3V 1Z2
- Completato
- Surrey Memorial Hospital
-
-
New Brunswick
-
Moncton, New Brunswick, Canada, E1C 4B7
- Completato
- The Moncton Hospital
-
-
Ontario
-
North York, Ontario, Canada, M4N 3M5
- Completato
- Sunnybrook Hospital
-
Saint Catharines, Ontario, Canada, L2S 0A9
- Completato
- Niagara Health - Marotta Family Hospital
-
Toronto, Ontario, Canada, M5B 1W8
- Completato
- St. Michael's Hospital
-
Toronto, Ontario, Canada, M5G 1X5
- Completato
- Mount Sinai Hospital
-
Toronto, Ontario, Canada, M5G 2C4
- Reclutamento
- University Health Network - Toronto General Hospital
-
Contatto:
- Shayan Wasim, MPH, BSc
- Numero di telefono: 4221 416-340-4800
- Email: shayan.wasim@uhn.ca
-
Investigatore principale:
- Matteo Parotto, MD, PhD
-
Contatto:
- Matteo Parotto, MD, PhD
- Numero di telefono: 416-340-3567
- Email: matteo.parotto@uhn.ca
-
Sub-investigatore:
- Alicia Grassi, MD
-
Toronto, Ontario, Canada, M5T 2S8
- Completato
- University Health Network - Toronto Western Hospital
-
-
Quebec
-
Montreal, Quebec, Canada, H2X 0C1
- Completato
- Centre hospitalier de l'Université de Montréal (CHUM)
-
-
-
-
-
Piedecuesta, Colombia
- Completato
- Hospital Internacional de Colombia
-
-
-
-
-
Castlebar, Irlanda, F23 H529
- Completato
- Mayo University Hospital
-
Cork, Irlanda, T12 DFK4
- Completato
- Cork University Hospital
-
Dublin, Irlanda, D07 R2WY
- Completato
- Mater Misericordiae University Hospital
-
Galway, Irlanda, H91 YR71
- Completato
- Galway University Hospitals
-
Waterford, Irlanda, X91 ER8E
- Non ancora reclutamento
- University Hospital Waterford
-
Contatto:
- Erin Crowley, PhD, MPharm
- Email: erin.crowley@ucc.ie
-
Contatto:
- Dulmi T Nawarathna, MBBS, MCAI, FCAI
- Numero di telefono: (+353) 0518482425
- Email: dulmi.nawarathna@hse.ie
-
Investigatore principale:
- Dulmi T Nawarathna, MBBS, MCAI, FCAI
-
Sub-investigatore:
- Sheeba Hakak, MBBS, FCARCSI, EDIC, HCM.
-
-
-
-
-
Kuwait City, Kuwait
- Completato
- Amiri Hospital
-
-
-
-
-
Auckland, Nuova Zelanda, 1023
- Completato
- Auckland City Hospital
-
Invercargill, Nuova Zelanda, 9812
- Completato
- Southland Hospital
-
Rotorua, Nuova Zelanda, 3010
- Completato
- Rotorua Hospital
-
-
-
-
-
Bath, Regno Unito, BA1 3NG
- Completato
- Royal United Hospitals Bath
-
Newcastle upon Tyne, Regno Unito, NE7 7DN
- Completato
- Freeman Hospital
-
-
-
-
-
Singapore, Singapore, 308433
- Completato
- Tan Tock Seng Hospital
-
-
-
-
Arizona
-
Tucson, Arizona, Stati Uniti, 85724-5114
- Completato
- Banner University Medical Centre
-
-
Arkansas
-
Little Rock, Arkansas, Stati Uniti, 72205
- Completato
- University of Arkansas for Medical Sciences
-
-
Florida
-
Gainesville, Florida, Stati Uniti, 32608
- Completato
- University of Florida
-
-
Illinois
-
Chicago, Illinois, Stati Uniti, 60637
- Completato
- The University of Chicago
-
-
Oregon
-
Portland, Oregon, Stati Uniti, 97239
- Completato
- Oregon Health & Science University
-
-
Texas
-
Houston, Texas, Stati Uniti, 77030
- Completato
- The University of Texas Health Science Center
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
All adult patients (≥18 years old) undergoing extubation of an endotracheal tube (including index extubation and re-extubations) after general anesthesia in the OR, out of OR anesthesia location or ICU during the specified enrollment window (up to 4 weeks).
Descrizione
Inclusion Criteria:
- Adult patients (≥18 years old)
- Undergoing extubation of an endotracheal tube (including index extubation and re-extubations) after general anesthesia in the OR, out of OR anesthesia location or ICU
- Undergoing extubation during the specified enrollment window
Exclusion Criteria:
- Patients will be excluded if the extubation is performed in the context of withdrawal of life support measures,
- Patients will be excluded if the extubation is performed for tracheostomy decannulation
For each patient who is not included, reasons for exclusion will be reported.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Modelli osservazionali: COHORT
- Prospettive temporali: PROSPECTIVE
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
At least one of the following, occurring within 60minutes after extubation (composite outcome): i) Severe hypoxemia ii) Cardiac arrest iii) Need for airway management
Lasso di tempo: Within 60 minutes after the end of extubation
|
The primary outcome will be the occurrence of at least one of the following (composite outcome) occurring within 60 minutes after the end of extubation: i) Severe hypoxemia (oxygen saturation as measured by pulse oximetry falls below SpO2 < 80% for > 5 minutes) ii) Cardiac arrest iii) Need for airway management (reintubation, insertion of a supraglottic airway, bag-mask ventilation). |
Within 60 minutes after the end of extubation
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Difficult airway and complications related to airway management if reintubation is required
Lasso di tempo: Within 60 minutes after the end of extubation
|
Difficult airway (i.e., experienced difficulty by an experienced airway manager with any or all of laryngoscopy or tracheal intubation, supraglottic airway use, face-mask ventilation, or front-of-neck airway) and complications related to airway management (e.g., esophageal intubation) if reintubation is required |
Within 60 minutes after the end of extubation
|
|
Planned and unplanned non-invasive respiratory support
Lasso di tempo: Within 60 minutes after the end of extubation
|
Planned and unplanned non-invasive respiratory support or high flow nasal cannula |
Within 60 minutes after the end of extubation
|
|
Emergency front of neck airway
Lasso di tempo: Within 60 minutes after the end of extubation
|
Emergency front of neck airway should airway management be required after extubation |
Within 60 minutes after the end of extubation
|
|
Cardiac arrhythmia requiring chemical or electrical treatment
Lasso di tempo: Within 60 minutes after the end of extubation
|
Cardiac arrhythmia requiring chemical or electrical treatment |
Within 60 minutes after the end of extubation
|
|
Severe Hypotension
Lasso di tempo: Within 60 minutes after the end of extubation
|
Severe hypotension (systolic arterial pressure < 65 mmHg recorded at any time or systolic arterial pressure < 90 mmHg for > 30 minutes or new need/increase of vasopressor and/or fluid load > 15 mL/kg) |
Within 60 minutes after the end of extubation
|
|
Severe Hypertension
Lasso di tempo: Within 60 minutes after the end of extubation
|
Severe hypertension (systolic blood pressure ≥180 mmHg and/or diastolic blood pressure ≥120 mmHg), |
Within 60 minutes after the end of extubation
|
|
Pulmonary aspiration
Lasso di tempo: Within 60 minutes after the end of extubation
|
Aspiration of gastric contents (gastric contents inhaled into the larynx and the respiratory tract) |
Within 60 minutes after the end of extubation
|
|
Barotrauma
Lasso di tempo: Within 60 minutes after the end of extubation
|
Pneumothorax/pneumo-mediastinum |
Within 60 minutes after the end of extubation
|
|
Dental injury
Lasso di tempo: Within 60 minutes after the end of extubation
|
Dental injury (notable change to the patient's dentition attributable to extubation or to reintubation, should this be required) |
Within 60 minutes after the end of extubation
|
|
Airways injury
Lasso di tempo: Within 60 minutes after the end of extubation
|
Airways injury (e.g., vocal cord damage, arytenoid dislocation |
Within 60 minutes after the end of extubation
|
|
Mortality
Lasso di tempo: Within 7 days after extubation
|
In-hospital mortality |
Within 7 days after extubation
|
|
Re-intubation
Lasso di tempo: Within 48 hours after extubation
|
Re-intubation within 48 hours of extubation |
Within 48 hours after extubation
|
Collaboratori e investigatori
Investigatori
- Investigatore principale: Matteo Parotto, MD, PhD, UHN
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
- 24-5811
- 4850 (Altro identificatore: Clinical Trials Ontario - CTO)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .